Home Tools
Log in
Cart

Search Result

Search Results for " mek inhibitor "

20

Compounds

Cat No. Product Name Synonyms Targets
T11993 MEK inhibitor MEK
MEK inhibitor is a potent MEK inhibitor with antitumor potency.
T28012 MEK-IN-4 MEK
MEK-IN-4 is a MEK inhibitor that can be used to study inflammatory diseases and cancer.
T6843 GDC-0623 G-868,GDC0623,RG 7421,MEK inhibitor 1 Apoptosis , MEK
GDC-0623 (RG 7421) is a potent and ATP-uncompetitive MEK1 inhibitor with Ki of 0.13 nM. Phase 1.
T2508 Binimetinib ARRY-438162,ARRY-162,MEK162 MEK , Autophagy
Binimetinib (ARRY-162) (MEK162, ARRY-162, ARRY-438162) is an orally available inhibitor of MEK1/2 (IC50: 12 nM) in a cell-free assay.
T6152 PD318088 MEK
PD318088 is a non-ATP competitive allosteric MEK1/2 inhibitor, binding simultaneously with ATP in a region of the MEK1 active site that is adjacent to the ATP-binding site.
T6692 TAK-733 TAK733,TAK 733 MEK
TAK-733 is an orally bioavailable small-molecule inhibitor of MEK1 and MEK2 (MEK1/2) with potential antineoplastic activity.
T2708 SL327 SL 327,SL-327 MEK , DNA/RNA Synthesis
SL327 is a selective inhibitor for MEK1/2 with IC50 of 0.18 μM/0.22 μM; able to transport through the blood-brain barrier.
T6785 BI-847325 Apoptosis , MEK , Aurora Kinase
BI-847325 is a selective dual inhibitor of MEK and aurora kinases (AK) with IC50 values of 4 and 15 nM for human MEK2 and AK-C, respectively.
T21295 BIX02189 BIX 02189 ERK , MEK
BIX02189 is a potent and selective inhibitor of MEK5 and ERK5(IC50 : 1.5 nM and 59 nM).
T21635 PD184161 MEK
PD184161 is a novel, orally-active MEK inhibitor. PD184161 inhibited MEK activity (IC50 = 10-100 nM) in a time- and concentration-dependent manner[1].
T2443 CI-1040 PD 184352 Apoptosis , MEK
CI-1040 (PD 184352) (PD184352) is an ATP non-competitive MEK1/2 inhibitor (IC50: 17 nM).
TMS2181 Trans-Zeatin (E)-Zeatin ERK , MEK , Endogenous Metabolite
trans-Zeatin ((E)-Zeatin) is the member of the plant growth hormone family known as cytokinins, which regulate cell division, development, and nutrient processing.
T2623 PD98059 PD 98059 ERK , Aryl Hydrocarbon Receptor , MEK , Autophagy
PD98059 is an MEK inhibitor that inhibits MEK1 and MEK2 (IC50=2/50 μM) and is non-ATP-competitive. PD98059 is also antagonistic as a ligand for AHR. PD98059 inhibits autophagy.
T7610 GW284543 UNC10225170 MEK
GW284543 (UNC10225170) is a selective inhibitor of MEK5 .
T6189 Mirdametinib PD325901,PD0325901 Apoptosis , MEK , Autophagy
Mirdametinib (PD325901) is an MEK inhibitor (IC50=0.33 nM) with selective, non-ATP-competitive, and oral activity. Mirdametinib exhibits antitumor activity by inhibiting p-ERK1/2 expression and inducing apoptosis.
T21980 PD 198306 MEK
PD 198306 is a selective inhibitor of MAPK/ERK-kinase (MEK) with antihyperalgesic effects. PD 198306 reduces the Streptozocin-induced increase in the level of active ERK1.
T5412 RO4987655 CH4987655,RG7167 MEK
RO4987655 (RG7167) is an orally active and highly selective MEK inhibitor (IC50: 5.2 nM for MEK1/MEK2).
T6971 Ro 5126766 CH5126766,Avutometinib,VS-6766,RO5126766 Raf , MEK
RO5126766 (CH5126766) is a dual RAF/MEK inhibitor with IC50 of 8.2 nM, 19 nM, 56 nM, and 160 nM for BRAF V600E, BRAF, CRAF, and MEK1, respectively. Phase 1.
T6760 APS-2-79 hydrochloride APS-2-79 HCl,APS-2-79 MEK , MAPK
APS-2-79 hydrochloride (APS-2-79 HCl) is a MAPK antagonist that modulating KSR-dependent MAPK signalling by antagonizing RAF heterodimerization as well as the conformational changes required for phosphorylation and activ...
T1144L Lidocaine Hydrochloride hydrate EGFR , Sodium Channel
Lidocaine Hydrochloride hydrate is an amide local anesthetic, has anti-inflammatory property.
1 2 3 4
TargetMol